National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2014 Biomarker Working Group Report.

@article{Paczesny2015NationalIO,
  title={National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2014 Biomarker Working Group Report.},
  author={Sophie Paczesny and Frances T Hakim and Joseph A Pidala and Kenneth R. Cooke and Julia Tait Lathrop and Linda M. Griffith and John A Hansen and Madan H. Jagasia and D. Mikl{\'o}s and Steven Z Pavletic and Robertson Parkman and Estelle Russek-Cohen and Mary E D Flowers and Stephanie J Lee and Paul J Martin and Georgia B. Vogelsang and Marc K Walton and Kirk R Schultz},
  journal={Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation},
  year={2015},
  volume={21 5},
  pages={780-92}
}
Biology-based markers to confirm or aid in the diagnosis or prognosis of chronic graft-versus-host disease (GVHD) after allogeneic hematopoietic cell transplantation or monitor its progression are critically needed to facilitate evaluation of new therapies. Biomarkers have been defined as any characteristic that is objectively measured and evaluated as an indicator of a normal biological or pathogenic process, or of a pharmacologic response to a therapeutic intervention. Applications of… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 5 times over the past 90 days. VIEW TWEETS
24 Citations
92 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 24 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 92 references

Similar Papers

Loading similar papers…